ALX ONCOLOGY HOLDINGS INC (ALXO) Net margin 2018–2020
ALX ONCOLOGY HOLDINGS INC (ALXO) net profit margin by fiscal year — reported net income divided by reported revenue.
-3869.7%FY2020 · since FY2018: -664.3% → -3869.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -3869.7% | -3468.5 pp |
| FY2019 | -401.2% | +263.1 pp |
| FY2018 | -664.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ALXO financial trends
ALXO RevenueALXO Net incomeALXO Gross profitALXO Gross marginALXO Operating incomeALXO Operating marginALXO Operating cash flowALXO Free cash flowALXO Capital expendituresALXO Return on equityALXO Stock buybacksALXO Dividends paidALXO Total assetsALXO Total liabilitiesALXO Shareholders’ equityALXO overview →